Holding(s) in Company | 13-Oct-2025 | 16:21 | RNS |
Half-year Report | 30-Sep-2025 | 07:00 | RNS |
NHS (UCLH) Risk of Ovarian Cancer (ROCA) launch | 25-Sep-2025 | 07:00 | RNS |
Holding(s) in Company | 24-Sep-2025 | 17:58 | RNS |
Stmnt re Share Price Movement | 17-Sep-2025 | 10:42 | RNS |
Notice of Results | 05-Sep-2025 | 07:00 | RNS |
Trading update | 26-Aug-2025 | 07:00 | RNS |
De Novo Update – FDA Supervisory Review | 07-Jul-2025 | 07:00 | RNS |
Result of AGM | 30-Jun-2025 | 11:42 | RNS |
Final Results | 04-Jun-2025 | 07:00 | RNS |
Notice of Results | 16-May-2025 | 07:00 | RNS |
De Novo Submission Update | 30-Apr-2025 | 07:00 | RNS |
Grant of Share Options & PDMR Dealings | 26-Mar-2025 | 07:45 | RNS |
Holding(s) in Company | 06-Mar-2025 | 14:24 | RNS |
Holding(s) in Company | 05-Mar-2025 | 15:02 | RNS |
Currency | UK Pounds |
Share Price | 3.60p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 5.80 |
52 Week Low | 1.40 |
Volume | 213,126 |
Shares Issued | 286.88m |
Market Cap | £10.33m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:51 | 152,571 @ 3.29p |
12:35 | 13,495 @ 3.29p |
11:50 | 22,727 @ 3.29p |
11:28 | 1,326 @ 3.77p |
11:06 | 200 @ 3.20p |
CEO | Matthew Heaton Walls |
CFO | Paul Andrew Peter Foulger |
COO | Jordi Puig Gilberte |
You are here: research